chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-11 AccNo: 0001567619-19-002922 Size: 65 KB 网页链接
$Menlo Therapeutics(MNLO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-02-01 AccNo: 0001564590-19-001694 Size: 1 MB 网页链接
$Menlo Therapeutics(MNLO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-02-01 AccNo: 0001564590-19-001694 Size: 1 MB 网页链接
$Menlo Therapeutics(MNLO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-07 AccNo: 0001193125-19-003563 Size: 33 KB 网页链接
$Menlo Therapeutics, Inc.(MNLO)$ 8-K - Current report Filed: 2018-12-10 AccNo: 0001564590-18-030737 Size: 48 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Menlo Therapeutics, Inc.(MNLO)$ 8-K - Current report Filed: 2018-11-13 AccNo: 0001564590-18-029102 Size: 22 KBItem 8.01: Other Events 网页链接
$Menlo Therapeutics, Inc.(MNLO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-07 AccNo: 0001564590-18-028098 Size: 5 MB 网页链接
$Menlo Therapeutics, Inc.(MNLO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-07 AccNo: 0001564590-18-028098 Size: 5 MB 网页链接
$Menlo Therapeutics, Inc.(MNLO)$ 8-K - Current report Filed: 2018-11-07 AccNo: 0001564590-18-028043 Size: 145 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Menlo Therapeutics, Inc.(MNLO)$ 8-K - Current report Filed: 2018-11-07 AccNo: 0001564590-18-028043 Size: 145 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接